⌘K

Home/Filings/4/0001493152-23-032150

4//SEC Filing

Marquet Magda 4

Accession 0001493152-23-032150

CIK 0001873835other

View on SEC.gov Company Profile

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 5:46 PM ET

Size

4.6 KB

Accession

0001493152-23-032150

Insider Transaction Report

Form 4

Period: 2023-09-06

Immix Biopharma, Inc.IMMX

Director

Transactions

Purchase
Common Stock
2023-09-06$2.47/sh+9,000$22,213→ 20,000 total(indirect: By LLC)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Immix Biopharma, Inc.

CIK 0001873835

Entity typeother

Related Parties

1

filerCIK 0001631486

Filing Metadata

Form type: 4
Filed: Sep 7, 8:00 PM ET
Accepted: Sep 8, 5:46 PM ET
Size: 4.6 KB

View on SEC.gov